Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of action

被引:84
作者
Menaldino, DS
Bushnev, A
Sun, AM
Liotta, DC
Symolon, H
Desai, K
Dillehay, DL
Peng, Q
Wang, E
Allegood, J
Trotman-Pruett, S
Sullards, MC
Merrill, AH [1 ]
机构
[1] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA
[2] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA
[3] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA
[4] Emory Univ, Div Anim Resources, Atlanta, GA 30322 USA
[5] Emory Univ, Div Biol & Biomed Sci, Atlanta, GA 30322 USA
[6] Emory Univ, Dept Chem, Atlanta, GA 30322 USA
关键词
sphingoid base; sphingolipid; fumonisins; toxicity; cancer;
D O I
10.1016/S1043-6618(03)00054-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The sphingoid base backbones of sphingolipids (sphingosines, sphinganines, 4-hydroxysphinganines and others) are highly bioactive species directly and-in most cases-as their metabolites, the N-acyl-sphingoid bases (ceramides) and sphingoid base 1-phosphates. The complexity of these compounds affords many opportunities to prepare synthetic analogs for studies of sphingolipid metabolism and the functions of the sphingoid bases and metabolites. Described in this review are methods for the preparation of libraries of sphingoid bases, including a series of 1-deoxy-analogs, as well as information about their metabolism and biological activities. Findings with these compounds have uncovered some of the complications of working with compounds that mimic a naturally occurring biomodulator-such as that they are sometimes metabolized by enzymes that handle the endogenous compounds and the products may have potent (and unexpected) biological activities. Through studying such compounds, there is now a greater understanding of the metabolism and mechanism(s) of action of naturally occurring sphingoid bases as well as of these analogs. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:373 / 381
页数:9
相关论文
共 42 条
[31]  
Schmelz EM, 2001, CANCER RES, V61, P6723
[32]   Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases [J].
Schmelz, EM ;
Dombrink-Kurtzman, MA ;
Roberts, PC ;
Kozutsumi, Y ;
Kawasaki, T ;
Merrill, AH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 148 (02) :252-260
[33]   Re-evaluation of primary structure, topology, and localization of Scamper, a putative intracellular Ca2+ channel activated by sphingosylphosphocholine [J].
Schnurbus, R ;
Tonelli, DD ;
Grohovaz, F ;
Zacchetti, D .
BIOCHEMICAL JOURNAL, 2002, 362 (01) :183-189
[34]  
SCHROEDER JJ, 1994, J BIOL CHEM, V269, P3475
[35]  
SCHWARTZ GK, 1997, CLIN CANCER RES, V3, P343
[36]   Changing J774A.1 cells to new medium perturbs multiple signaling pathways, including the modulation of protein kinase C by endogenous sphingoid bases [J].
Smith, ER ;
Jones, PL ;
Boss, JM ;
Merrill, AH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (09) :5640-5646
[37]  
Smith ER, 2000, METHOD ENZYMOL, V312, P361
[38]   Sphingosine 1-phosphate, a key cell signaling molecule. [J].
Spiegel, S ;
Milstien, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (29) :25851-25854
[39]   CHARACTERISTICS OF THE GROWTH-INHIBITION AND CYTOTOXICITY OF LONG-CHAIN (SPHINGOID) BASES FOR CHINESE-HAMSTER OVARY CELLS - EVIDENCE FOR AN INVOLVEMENT OF PROTEIN KINASE-C [J].
STEVENS, VL ;
NIMKAR, S ;
JAMISON, WCL ;
LIOTTA, DC ;
MERRILL, AH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1051 (01) :37-45
[40]  
SULLARDS MC, 2001, SCI STKE, V67, pPL1